Targeted Treatment of Age-Related Fibromyalgia with Supplemental Coenzyme Q10.

@article{Hargreaves2021TargetedTO,
  title={Targeted Treatment of Age-Related Fibromyalgia with Supplemental Coenzyme Q10.},
  author={Iain P. Hargreaves and David Mantle},
  journal={Advances in experimental medicine and biology},
  year={2021},
  volume={1286},
  pages={
          77-85
        }
}
  • I. Hargreaves, D. Mantle
  • Published 2021
  • Medicine, Biology, Psychology
  • Advances in experimental medicine and biology
Fibromyalgia is a common chronic pain condition of unknown aetiology, although mitochondrial dysfunction, oxidative stress, and inflammation have been implicated in the pathophysiology of this disorder. Treatment generally involves physiotherapy, anticonvulsants, and antidepressant therapy; however, the symptomatic relief conferred by these treatments can be very variable, and there is a need for additional therapeutic strategies. One such treatment which is gaining a lot of interest is the use… 
1 Citations
Coenzyme Q at the Hinge of Health and Metabolic Diseases
TLDR
The importance of coenzyme Q levels and its reactions involved in aging and age-associated metabolic disorders, and how the strategy of its supplementation has had benefits for combating these diseases and for physical performance in aging.

References

SHOWING 1-10 OF 34 REFERENCES
Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia?
TLDR
The hypothesis that CoQ10 have a potential therapeutic effect in FM is led to, and new potential molecular targets for the therapy of this disease are indicated.
Fibromyalgia and nutrition: Therapeutic possibilities?
Fibromyalgia and chronic fatigue: the underlying biology and related theoretical issues.
TLDR
This chapter will focus on inflammatory and oxidative stress pathways and on the neuroendocrine system, which have been more commonly examined and suggest a role for the hypothalamic-pituitary-adrenal axis and cortisol in the pathogenesis of these syndromes.
Coenzyme q10 regulates serotonin levels and depressive symptoms in fibromyalgia patients: results of a small clinical trial.
TLDR
The effect of 40 days of CoQ10 versus placebo supplementation on serotonin levels in platelets from FM patients and depressive symptoms improvement is shown, following up the earlier work on the mechanisms of therapeutic effects of Co Q10 in FM.
Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia?
TLDR
Results lead to the hypothesis that inflammation could be a mitochondrial dysfunction-dependent event implicated in the pathophysiology of FM in several patients indicating at mitochondria as a possible new therapeutic target.
Oxidative Stress Correlates with Headache Symptoms in Fibromyalgia: Coenzyme Q10 Effect on Clinical Improvement
TLDR
A role for mitochondrial dysfunction and oxidative stress in the headache symptoms associated with FM is suggested and CoQ10 supplementation should be examined in a larger placebo controlled trial as a possible treatment in FM.
Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction
TLDR
Findings provide new evidence that CoQ10 supplementation provides further benefit for relieving pain sensation in pregabalin-treated FM patients, possibly via improving mitochondrial function, reducing inflammation, and decreasing brain activity.
NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10.
TLDR
Results show an important role for the NLRP3 inflammasome in the pathogenesis of FM, and the capacity of CoQ10 in the control of inflammaome is suggested to be a new therapeutic intervention for the disease.
Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia?
TLDR
The hypothesis that mitochondrial dysfunction-dependent events could be a marker of differentiation between CFS and FM, indicating the mitochondria as a new potential therapeutic target for these conditions is led to.
Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study.
TLDR
In patients with FM, increases over time in serum levels and/or PBMC-stimulated activity of soluble factors whose release is stimulated by substance P are found, hypothesized that they may play a role in modulating FM symptoms.
...
...